These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
124 related articles for article (PubMed ID: 21688628)
21. Proton pump inhibitor co-therapy with nonsteroidal anti-inflammatory drugs--nice or necessary? Laine L Rev Gastroenterol Disord; 2004; 4 Suppl 4():S33-41. PubMed ID: 15580145 [TBL] [Abstract][Full Text] [Related]
22. Discontinuation of low-dose aspirin therapy after peptic ulcer bleeding increases risk of death and acute cardiovascular events. Derogar M; Sandblom G; Lundell L; Orsini N; Bottai M; Lu Y; Sadr-Azodi O Clin Gastroenterol Hepatol; 2013 Jan; 11(1):38-42. PubMed ID: 22975385 [TBL] [Abstract][Full Text] [Related]
23. [Upper gastrointestinal bleeding in patients treated by low-dose aspirin]. Capet C; Czernichow P; Dupas JL; Goria O; Gouérou H; Hochain P; Amouretti M; Herman H; Colin R Gastroenterol Clin Biol; 2001 Mar; 25(3):233-8. PubMed ID: 11395668 [TBL] [Abstract][Full Text] [Related]
24. [Significance of H. pylori eradication in treatment and prevention for low-dose aspirin induced gastric ulcer of elderly]. Kato M; Ono S; Yoshida T; Mabe K; Shimizu Y; Asaka M Nihon Rinsho; 2010 Nov; 68(11):2089-95. PubMed ID: 21061538 [TBL] [Abstract][Full Text] [Related]
25. Significant gastrointestinal bleeding in patients at risk of coronary stent thrombosis. Dai X; Makaryus AN; Makaryus JN; Jauhar R Rev Cardiovasc Med; 2009; 10(1):14-24. PubMed ID: 19367228 [TBL] [Abstract][Full Text] [Related]
26. Nitrovasodilators, low-dose aspirin, other nonsteroidal antiinflammatory drugs, and the risk of upper gastrointestinal bleeding. Lanas A; Bajador E; Serrano P; Fuentes J; Carreño S; Guardia J; Sanz M; Montoro M; Sáinz R N Engl J Med; 2000 Sep; 343(12):834-9. PubMed ID: 10995862 [TBL] [Abstract][Full Text] [Related]
27. Update on aspirin in the treatment and prevention of cardiovascular disease. Hennekens CH Am J Manag Care; 2002 Dec; 8(22 Suppl):S691-700. PubMed ID: 12512736 [TBL] [Abstract][Full Text] [Related]
28. The impact of low-dose aspirin on endoscopic gastric and duodenal ulcer rates in users of a non-selective non-steroidal anti-inflammatory drug or a cyclo-oxygenase-2-selective inhibitor. Goldstein JL; Lowry SC; Lanza FL; Schwartz HI; Dodge WE Aliment Pharmacol Ther; 2006 May; 23(10):1489-98. PubMed ID: 16669964 [TBL] [Abstract][Full Text] [Related]
31. The preventive effect of low-dose aspirin in the development of stress ulceration in rats. Kumashiro R; Montgomery O; Langman A; Kholoussy AM; Matsumoto T Am Surg; 1983 Aug; 49(8):423-7. PubMed ID: 6614664 [TBL] [Abstract][Full Text] [Related]
32. Low-dose aspirin and upper gastrointestinal damage: epidemiology, prevention and treatment. Lanas A; Scheiman J Curr Med Res Opin; 2007 Jan; 23(1):163-73. PubMed ID: 17257477 [TBL] [Abstract][Full Text] [Related]
33. Efficacy of famotidine in the healing of active benign gastric ulceration: comparison of nonsteroidal anti-inflammatory- or aspirin-induced gastric ulcer and idiopathic gastric ulceration. Long Island Jewish Medical Center Acid-Peptic Study Group. Bank S; Blumstein M; Greenberg RE; Magier D; Lavin PT Clin Ther; 1993; 15(1):36-45. PubMed ID: 8458053 [TBL] [Abstract][Full Text] [Related]
34. [Guideline for prophylaxis and treatment of NSAID-associated gastric ulcerations]. Hiraishi H; Yamagata M; Yoneda M; Shimada T Nihon Rinsho; 2007 Oct; 65(10):1812-7. PubMed ID: 17926529 [TBL] [Abstract][Full Text] [Related]
35. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors. Lazzaroni M; Bianchi Porro G Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473 [TBL] [Abstract][Full Text] [Related]
36. Randomised clinical trial: prevention of recurrence of peptic ulcers by rabeprazole in patients taking low-dose aspirin. Iwakiri R; Higuchi K; Kato M; Fujishiro M; Kinoshita Y; Watanabe T; Takeuchi T; Yamauchi M; Sanomura M; Nakagawa H; Sugisaki N; Okada Y; Ogawa H; Arakawa T; Fujimoto K Aliment Pharmacol Ther; 2014 Oct; 40(7):780-95. PubMed ID: 25100080 [TBL] [Abstract][Full Text] [Related]
37. Celecoxib plus aspirin versus naproxen and lansoprazole plus aspirin: a randomized, double-blind, endoscopic trial. Goldstein JL; Cryer B; Amer F; Hunt B Clin Gastroenterol Hepatol; 2007 Oct; 5(10):1167-74. PubMed ID: 17916545 [TBL] [Abstract][Full Text] [Related]
38. [Role of proton pump inhibitor in the management of low dose aspirin related ulcerations]. Hiraishi H; Shimada T Nihon Rinsho; 2010 Nov; 68(11):2096-101. PubMed ID: 21061539 [TBL] [Abstract][Full Text] [Related]
39. [Low-dose aspirin in the long-term treatment of the patient with ischemic heart disease]. Magnani B; Semprini F Cardiologia; 1994 Dec; 39(12 Suppl 1):15-21. PubMed ID: 7634259 [TBL] [Abstract][Full Text] [Related]
40. Impact of upper gastrointestinal lesions in patients on low-dose aspirin therapy: preliminary study. Kawai T; Watanabe M; Yamashina A J Gastroenterol Hepatol; 2010 May; 25 Suppl 1():S23-30. PubMed ID: 20586861 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]